tm logo

Monitor this mark

View On USPTO

ANAPTYSBIO V
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 13 Aug 2024

Last Applicant/ Owned by

AnaptysBio, Inc.

Suite 210

San Diego

CA

92121

Serial Number

90663689 filed on 22nd Apr 2021

Registration Number

N/A

Correspondent Address

Anne E. Naffziger

Anne E. Naffziger Leydig, Voit & Mayer, Ltd.

Suite 375

Walnut Creek, CA 94596

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ANAPTYSBIO V

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use Biological preparations for the treatment of cancer and inflammation

Classification Information

Class [005]
Pharmaceutical Products

Biological preparations for the treatment of cancer and inflammation

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 90663689

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 753966

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History

Show more

Status DateAction Taken
13th Aug 2024SOU EXTENSION 5 GRANTED
13th Aug 2024SOU EXTENSION 5 FILED
13th Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Aug 2024SOU TEAS EXTENSION RECEIVED
13th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Mar 2024SOU EXTENSION 4 GRANTED
12th Mar 2024SOU TEAS EXTENSION RECEIVED
12th Mar 2024SOU EXTENSION 4 FILED
09th Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Sep 2023SOU EXTENSION 3 GRANTED